<DOC>
	<DOCNO>NCT00916487</DOCNO>
	<brief_summary>The purpose study determine whether enzymatic product Frucosin ( R ) able degrade fructose vivo small intestine patient know fructose malabsorption measure hydrogen expiratory air .</brief_summary>
	<brief_title>Efficacy Fructose Metabolizing Enzymatic Product Fructose Malabsorption</brief_title>
	<detailed_description>Fructose malabsorption digestive disorder uptake fructose small intestine deficient . This lead increase concentration fructose large intestine intake fructose-rich meal . The exzess fructose degrade intestinal microbe CO2 , CH4 , H2 short chain fatty acid cause symptom like bloating , diarrhea , flatulence stomach pain . The clinical diagnosis require hydrogen breath test challenge fructose . After oral challenge fructose emerge hydrogen measure expiratory air . A fructose malabsorption diagnose hydrogen expiratory air reach 20ppm . In course study participant take 2 hydrogen breath test . Before test participant take either active treatment ( Fructosin ( R ) ) placebo . The active treatment reduce exhale hydrogen indicate reduce concentration fructose large intestine fructose metabolization verum .</detailed_description>
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<criteria>diagnose fructose malabsorption Gravidity diabetes mellitus recent gastrointestinal surgery recent endoscopy recent antibiotic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>